А.П. Бурлака

741 total citations
54 papers, 536 citations indexed

About

А.П. Бурлака is a scholar working on Molecular Biology, Biophysics and Materials Chemistry. According to data from OpenAlex, А.П. Бурлака has authored 54 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Biophysics and 13 papers in Materials Chemistry. Recurrent topics in А.П. Бурлака's work include Electron Spin Resonance Studies (9 papers), Nanoparticle-Based Drug Delivery (7 papers) and Free Radicals and Antioxidants (7 papers). А.П. Бурлака is often cited by papers focused on Electron Spin Resonance Studies (9 papers), Nanoparticle-Based Drug Delivery (7 papers) and Free Radicals and Antioxidants (7 papers). А.П. Бурлака collaborates with scholars based in Ukraine, Russia and United Kingdom. А.П. Бурлака's co-authors include S. M. Lukin, Uwe Ritter, Svitlana Prylutska, Yu. І. Prylutskyy, P. Scharff, Orel Vé, І. І. Grynyuk, T. Mitrelias, M. Tselepi and C. H. W. Barnes and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nanotechnology and Journal of Magnetism and Magnetic Materials.

In The Last Decade

А.П. Бурлака

46 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
А.П. Бурлака Ukraine 12 181 178 137 106 99 54 536
Mayumi Ikeda Japan 16 103 0.6× 217 1.2× 53 0.4× 242 2.3× 161 1.6× 46 734
Kai‐Cheng Yan China 14 280 1.5× 251 1.4× 99 0.7× 230 2.2× 83 0.8× 25 776
Najmeh Sadat Hosseini Motlagh Iran 10 124 0.7× 229 1.3× 29 0.2× 93 0.9× 122 1.2× 14 465
Kenji Tsukigawa Japan 12 162 0.9× 342 1.9× 58 0.4× 255 2.4× 362 3.7× 30 731
Kongpeng Lv China 13 206 1.1× 297 1.7× 30 0.2× 279 2.6× 111 1.1× 19 767
Marwa M. Afifi Egypt 12 121 0.7× 161 0.9× 19 0.1× 211 2.0× 92 0.9× 21 480
Yuping Han China 14 125 0.7× 186 1.0× 37 0.3× 199 1.9× 155 1.6× 36 587
Haihong He China 12 249 1.4× 219 1.2× 56 0.4× 126 1.2× 12 0.1× 25 586
Gaoxin Zhou China 14 265 1.5× 398 2.2× 60 0.4× 202 1.9× 183 1.8× 34 846
Christine Contino-Pepin France 13 97 0.5× 148 0.8× 128 0.9× 180 1.7× 50 0.5× 37 521

Countries citing papers authored by А.П. Бурлака

Since Specialization
Citations

This map shows the geographic impact of А.П. Бурлака's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by А.П. Бурлака with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites А.П. Бурлака more than expected).

Fields of papers citing papers by А.П. Бурлака

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by А.П. Бурлака. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by А.П. Бурлака. The network helps show where А.П. Бурлака may publish in the future.

Co-authorship network of co-authors of А.П. Бурлака

This figure shows the co-authorship network connecting the top 25 collaborators of А.П. Бурлака. A scholar is included among the top collaborators of А.П. Бурлака based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with А.П. Бурлака. А.П. Бурлака is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Бурлака, А.П., et al.. (2023). THE CHANGES OF NO LEVEL AND RNase ACTIVITY IN TUMOR TISSUE ACCOMPANYING THE PROGRESSION OF PROSTATE CANCER. Experimental Oncology. 44(2). 159–162. 1 indexed citations
2.
Бурлака, А.П., et al.. (2021). Redox dependent features of tumors, adipose tissue, neutrophiles and platelets in patients with metastatic colorectal cancer. Experimental Oncology. 43(3). 261–265. 3 indexed citations
3.
4.
Бурлака, А.П., et al.. (2020). Cytochrome P450 content in primary tumors and liver metastases of patients with metastatic colorectal cancer. Experimental Oncology. 42(4). 330–332. 3 indexed citations
5.
Бурлака, А.П., et al.. (2020). Tumor microenvironment changes tumor cell sensitivity to action of energy metabolism modifiers. Experimental Oncology. 42(3). 192–196. 1 indexed citations
6.
Vé, Orel, M. Tselepi, T. Mitrelias, et al.. (2019). The comparison between superparamagnetic and ferromagnetic iron oxide nanoparticles for cancer nanotherapy in the magnetic resonance system. Nanotechnology. 30(41). 415701–415701. 20 indexed citations
7.
Бурлака, А.П., et al.. (2019). Tumor-associated redox state in metastatic colorectal cancer. Experimental Oncology. 41(2). 148–152. 3 indexed citations
8.
Бурлака, А.П., et al.. (2019). Molecular mechanisms of oxidation damage and liver cell dysfunction in patients with metastatic colorectal cancer. Experimental Oncology. 41(4). 328–334. 7 indexed citations
9.
Бурлака, А.П., et al.. (2019). Redox state of adipose tissue for patients with gastric cancer and its connection with the body mass index and distance from the tumor. Obesity Research & Clinical Practice. 14(1). 34–38. 4 indexed citations
10.
Vé, Orel, M. Tselepi, T. Mitrelias, et al.. (2019). Nonlinear Magnetochemical Effects in Nanotherapy of Walker-256 Carcinosarcoma. ACS Applied Bio Materials. 2(9). 3954–3963. 6 indexed citations
11.
Vé, Orel, M. Tselepi, T. Mitrelias, et al.. (2018). Nanomagnetic Modulation of Tumor Redox State. Nanomedicine Nanotechnology Biology and Medicine. 14(4). 1249–1256. 16 indexed citations
13.
Misyak, Sarah, et al.. (2016). Antiradical, Antimetastatic and Antitumor Activity of Kaolin Preparation “Kremnevit”. SHILAP Revista de lepidopterología. 5 indexed citations
14.
Vé, Orel, M. Tselepi, T. Mitrelias, et al.. (2014). Magnetic properties and antitumor effect of nanocomplexes of iron oxide and doxorubicin. Nanomedicine Nanotechnology Biology and Medicine. 11(1). 47–55. 69 indexed citations
15.
Бурлака, А.П., et al.. (2013). Electron Paramagnetic Resonance Study of Tumor Affected Bone Marrow. Cancer Microenvironment. 6(3). 273–276. 11 indexed citations
16.
Prylutska, Svitlana, et al.. (2011). Using water-soluble C60 fullerenes in anticancer therapy. Cancer Nanotechnology. 2(1-6). 105–110. 45 indexed citations
17.
Vé, Orel, et al.. (2011). MECHANICAL HETEROGENIZATION OF LEWIS LUNG CARCINOMA CELLS CAN IMPROVE ANTIMETASTATIC EFFECT OF DENDRITIC CELLS. Journal of Mechanics in Medicine and Biology. 12(3). 1250037–1250037. 1 indexed citations
18.
Scharff, P., Uwe Ritter, Olga Matyshevska, et al.. (2008). Therapeutic Reactive Oxygen Generation. Tumori Journal. 94(2). 278–283. 27 indexed citations
19.
Scharff, P., Uwe Ritter, Olga Matyshevska, et al.. (2008). Therapeutic reactive oxygen generation.. PubMed. 94(2). 278–83. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026